PureTech Health (UK) Insiders
| PRTC Stock | 126.60 1.60 1.25% |
PureTech Health employs about 56 people. The company is managed by 24 executives with a total tenure of roughly 131 years, averaging almost 5.0 years of service per executive, having 2.33 employees per reported executive. Breaking down PureTech Health's management performance can provide insight into the firm performance.
| Eric Elenko President CoFounder President |
| Dr JD President Secretary, President |
PureTech |
PureTech Health Management Team Effectiveness
The company has return on total asset (ROA) of (0.1295) % which means that it has lost $0.1295 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0944 %, meaning that it generated $0.0944 on every $100 dollars invested by stockholders. PureTech Health's management efficiency ratios could be used to measure how well PureTech Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, PureTech Health's Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 146.2 M in 2026, whereas Other Assets are likely to drop 1,092 in 2026.Common Stock Shares Outstanding is likely to drop to about 280.2 M in 2026. Net Loss is likely to gain to about (66.2 M) in 2026PureTech Health owns a total of 241.68 Million outstanding shares. The majority of PureTech Health plc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PureTech Health plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PureTech Health. Please pay attention to any change in the institutional holdings of PureTech Health plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2012-03-31 | Previous Quarter 269.7 M | Current Value 240 M | Avarage Shares Outstanding 243.1 M | Quarterly Volatility 58.4 M |
PureTech Health Workforce Comparison
PureTech Health plc is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1.48 Million. PureTech Health adds roughly 56.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 7.93 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (25.9) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $25.9. PureTech Health plc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. PureTech Health plc Price Series Summation is a cross summation of PureTech Health price series and its benchmark/peer.
PureTech Health Notable Stakeholders
A PureTech Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PureTech Health often face trade-offs trying to please all of them. PureTech Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PureTech Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David Elmaleh | CoFounder Advisor | Profile | |
| Daphne Zohar | Senior Founder | Profile | |
| Bennett MD | CoFounder Advisor | Profile | |
| Eric Elenko | CoFounder President | Profile | |
| Dr JD | Secretary, President | Profile | |
| Dr Langer | CoFounder Director | Profile | |
| Frank Salisbury | Senior Strategy | Profile | |
| Michael Chen | Chief Seaport | Profile | |
| Anita JD | Senior Property | Profile | |
| Lauren MBA | Chief Officer | Profile | |
| RDN MS | Chief Officer | Profile | |
| Spencer Ball | Executive Resources | Profile | |
| III JD | General Secretary | Profile | |
| Joseph Bolen | Chief Officer | Profile | |
| Aleksandra MD | Head Oncology | Profile | |
| Kana DeLuca | Associate Relations | Profile | |
| William CPA | Controller | Profile | |
| Eric MBA | Chief Officer | Profile | |
| Dilip Kodira | Head Science | Profile | |
| Allison Talbot | Senior Relations | Profile | |
| Cheryl Murphy | Head Strategy | Profile | |
| Robert JD | Interim Officer | Profile | |
| MPH MD | Senior Affairs | Profile |
About PureTech Health Management Performance
The success or failure of an entity such as PureTech Health plc often depends on how effective the management is. PureTech Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PureTech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PureTech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PureTech Health is entity of United Kingdom. It is traded as Stock on LSE exchange.
Please note, the imprecision that can be found in PureTech Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of PureTech Health plc. Check PureTech Health's Beneish M Score to see the likelihood of PureTech Health's management manipulating its earnings.
PureTech Health Workforce Analysis
Traditionally, organizations such as PureTech Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PureTech Health within its industry.PureTech Health Manpower Efficiency
Return on PureTech Health Manpower
| Revenue Per Employee | 77.1K | |
| Revenue Per Executive | 179.8K | |
| Net Income Per Employee | 496.1K | |
| Net Income Per Executive | 1.2M | |
| Working Capital Per Employee | 6.2M | |
| Working Capital Per Executive | 14.4M |
Additional Tools for PureTech Stock Analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.